ATTENTION: HealthWell Foundation headquarters and hotline will be closed on Wednesday, December 25, 2024, in observance of the holiday and will re-open on Thursday, December 26, 2024, at 9:00 a.m. We encourage you to continue to use our Patient, Pharmacy and Provider Portals during this time. If you have a question that cannot be answered by visiting the portal, please send an email to [email protected]. We appreciate your patience and look forward to serving you. The HealthWell Team
Inflammatory Bowel Disease - Medicare Access (Medicare patients only)
Status
Closed
Closed Funds
This fund is temporarily closed to new patients due to lack of sufficient funding. Please continue to visit our Disease Funds page often, as replenished funds reopen as quickly as possible. If you currently have a grant with HealthWell, your grant will remain active for the entire 12 month grant cycle or until you have exhausted your allocated grant amount, whichever comes first. You can continue to use your pharmacy card or submit requests for reimbursements during your designated grant cycle.
Fund Type
CopayMaximum Award Level
Pharmacy Card Fund
YesMinimum CopayReimbursement Amount
Minimum Copay Reimbursement Amount
We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.
Minimum Premium
Reimbursement Amount
Household Income Limit
400% of the Federal Poverty Level(adjusted for household size and high
cost of living areas)
Treatments Covered
- Abrilada
- Adalimumab-adbm
- Adalimumab-afzb
- Adalimumab-atto
- Amitiza
- Amitriptyline Hydrochloride
- Amjevita
- Anaspaz
- Apriso
- Asacol
- Asacol Hd
- Atropine
- Avsola
- Azasan
- Azathioprine
- Azulfidine
- Balsalazide
- Belladona Alkaloids And Phenobarbital
- Bentyl
- Budesonide
- Butylscopolamine
- Canasa
- Celestone Soluspan
- Cilansetron
- Cimetropium Bromide
- Cimzia
- Cimzia Prefl
- Clorpactin Wcs-90v
- Colazal
- Cortastat
- Cyclosporine
- Cyltezo
- Delzicol
- Depo-medrol
- Desipramine Hydrochloride
- Dexamethasone
- Dicyclomine Hydrochloride
- Dipentum
- Domperidone
- Donnatal
- Enbrel
- Entocort
- Entyvio
- Erelzi
- Etanercept
- Etanercept-szzs
- Eticovo
- Etizolam
- Fluphenazine Hydrochloride
- Gastrocom
- Gengraf
- Hulio Sub Auto Inj Kit
- Hulio Sub Prefilled Syringe
- Humira
- Humira Pen
- Imuran
- Inflectra
- Infliximab
- Infliximab-abda
- Infliximab-dyyb
- Infliximab-qbtx
- Ixifi
- Lactobacillus
- Leukine
- Leuprolide Acetate
- Levosulpiride
- Levsin
- Lialda
- Librax
- Linzess
- Lomotil
- Loperamide
- Lotronex
- Mebeverine
- Medazepam
- Medrol
- Mercaptopurine
- Mesalamine
- Millipred
- Neoral
- Norpramin
- Nortriptyline Hydrochloride
- Orapred Odt
- Otilonium Bromide
- Pamelor
- Pentasa
- Phloroglucinol
- Pinaverium
- Prifinium Bromide
- Prozac
- Purinethol
- Purixan
- Remicade
- Renflexis
- Rheumatrex
- Rinvoq
- Rowasa
- Sandimmune
- Simponi
- Solu-medrol
- Sorbitol
- Stelara
- Surmontil
- Thalomid
- Tofranil
- Tremfya
- Trexall
- Trimebutine
- Tyruko
- Tysabri
- Uceris
- Viberzi
- Wezlana
- Xeljanz
- Xifaxan
- Yuflyma
Fund Definition
Assistance with the prescription drugs and biologics used in the treatment of inflammatory bowel disease.
Grant Utilization
HealthWell estimates that patients use an average of $1,610 during their 12-month grant period for this disease area.
Do I Qualify?
HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:
-
Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.
-
This is a Medicare Access Fund. In order to qualify for assistance through this fund, you must have Medicare. The Foundation will refer patients without Medicare to other programs, such as manufacturer patient assistance programs.
-
HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
-
If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.
About Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is an umbrella term used to describe disorders that involve chronic inflammation of your digestive tract. Types of IBD include:
- Ulcerative colitis. This condition causes long-lasting inflammation and sores (ulcers) in the innermost lining of your large intestine (colon) and rectum.
- Crohn’s disease. This type of IBD is characterized by inflammation of the lining of your digestive tract, which often spreads deep into affected tissues.
Both ulcerative colitis and Crohn’s disease usually involve severe diarrhea, abdominal pain, fatigue and weight loss. IBD can be debilitating and sometimes leads to life-threatening complications. Source: Mayo Clinic
Additional Educational Resources
You may also visit our Resource List to view other copayment organizations that may provide assistance.
